INMD vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

INMD

49.9
AI Score
VS
INMD Wins

DOCS

45.1
AI Score

Investment Advisor Scores

INMD

50score
Recommendation
HOLD

DOCS

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric INMD DOCS Winner
Revenue 370.50M 644.86M DOCS
Net Income 93.83M 196.10M DOCS
Gross Margin 78.5% 89.1% DOCS
Net Margin 25.3% 30.4% DOCS
Operating Income 85.39M 214.92M DOCS
ROE 13.7% 20.6% DOCS
ROA 12.2% 17.5% DOCS
Total Assets 766.43M 1.12B DOCS
Cash 302.54M 219.18M INMD
Current Ratio 9.88 6.09 INMD

Relative Price Performance (Last 90 Days)

INMD 1M: -6.5% · 3M: -5.1% DOCS 1M: +8.2% · 3M: +30.4%

Current Technical Phase

INMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.2%), weak momentum, RSI 28

RSI (14): 28.3 · Price: $14.05

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.2% over 20 days), RSI 66

RSI (14): 65.8 · Price: $28.50

Fundamentals Snapshot

Metric INMD DOCS
Market Cap — —
Forward P/E 10.2 17.6
Trailing P/E 11.7 33.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.9%
Operating Margin 0.1% 0.2%
EPS 1.21 0.85
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INMD is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.